MX9204866A - SYNTHETIC ARYLPOLYAMINS AS ANTAGONISTS OF EXCITING AMINO ACID NEUROTRANSMITTERS. - Google Patents

SYNTHETIC ARYLPOLYAMINS AS ANTAGONISTS OF EXCITING AMINO ACID NEUROTRANSMITTERS.

Info

Publication number
MX9204866A
MX9204866A MX9204866A MX9204866A MX9204866A MX 9204866 A MX9204866 A MX 9204866A MX 9204866 A MX9204866 A MX 9204866A MX 9204866 A MX9204866 A MX 9204866A MX 9204866 A MX9204866 A MX 9204866A
Authority
MX
Mexico
Prior art keywords
arylpolyamins
antagonists
synthetic
amino acid
acid neurotransmitters
Prior art date
Application number
MX9204866A
Other languages
Spanish (es)
Inventor
Nicholas Alex Saccomano
Robert Alfred Volkmann
Original Assignee
Pfizer
Nps Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Nps Pharma Inc filed Critical Pfizer
Publication of MX9204866A publication Critical patent/MX9204866A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/35Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/40Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56Amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00Metallocenes
    • C07F17/02Metallocenes of metals of Groups 8, 9 or 10 of the Periodic System

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX9204866A 1991-08-23 1992-08-21 SYNTHETIC ARYLPOLYAMINS AS ANTAGONISTS OF EXCITING AMINO ACID NEUROTRANSMITTERS. MX9204866A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74901491A 1991-08-23 1991-08-23

Publications (1)

Publication Number Publication Date
MX9204866A true MX9204866A (en) 1993-04-01

Family

ID=25011863

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9204866A MX9204866A (en) 1991-08-23 1992-08-21 SYNTHETIC ARYLPOLYAMINS AS ANTAGONISTS OF EXCITING AMINO ACID NEUROTRANSMITTERS.

Country Status (14)

Country Link
EP (1) EP0641312A1 (en)
JP (1) JPH06505996A (en)
CN (1) CN1069969A (en)
AU (1) AU2426392A (en)
BR (1) BR9206403A (en)
CA (1) CA2114798A1 (en)
CZ (1) CZ39994A3 (en)
FI (1) FI940833A0 (en)
HU (1) HU9400503D0 (en)
IL (1) IL102835A0 (en)
MX (1) MX9204866A (en)
PT (1) PT100801A (en)
WO (1) WO1993004036A1 (en)
ZA (1) ZA926314B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087765B2 (en) 1995-06-07 2006-08-08 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6017965A (en) * 1993-02-08 2000-01-25 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6071970A (en) * 1993-02-08 2000-06-06 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6211245B1 (en) 1993-02-08 2001-04-03 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6750244B2 (en) 1993-02-08 2004-06-15 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
JPH09509484A (en) 1994-02-08 1997-09-22 エヌピーエス・ファルマシューティカルズ,インコーポレイテッド Compounds active at novel sites on receptor-operated calcium channels useful in the treatment of neurological disorders and diseases
US20010004460A1 (en) * 1995-06-08 2001-06-21 Carla Rasmussen Klittich Process for the preparation of rice seed for sowing
AU2003231670B2 (en) * 1997-10-27 2006-06-08 Slil Biomedical Corporation Methods for modulating macrophage proliferation using polyamine analogs
US7087648B1 (en) 1997-10-27 2006-08-08 The Regents Of The University Of California Methods for modulating macrophage proliferation using polyamine analogs
US8198334B2 (en) 1997-10-27 2012-06-12 Pathologica Llc Methods for modulating macrophage proliferation in ocular disease using polyamine analogs
AU2002340224B2 (en) 2001-10-16 2008-11-27 Progen Pharmaceuticals, Inc Oligoamine compounds and derivatives thereof for cancer therapy
ATE400300T1 (en) * 2003-09-09 2008-07-15 Univ Florida POLYAMINE-METAL CHELATING CONJUGATES
CN103073448B (en) * 2012-12-29 2015-11-18 河南大学 Containing the polyamine derivative and its preparation method and application of aromatic ring structure

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037846A (en) * 1990-01-02 1991-08-06 Pfizer Inc. Indolyl-3 polyamines and their use as antagonists of excitatory amino acid neurotransmitters

Also Published As

Publication number Publication date
JPH06505996A (en) 1994-07-07
WO1993004036A1 (en) 1993-03-04
ZA926314B (en) 1994-02-21
FI940833A (en) 1994-02-22
CZ39994A3 (en) 1994-11-16
FI940833A0 (en) 1994-02-22
EP0641312A1 (en) 1995-03-08
CA2114798A1 (en) 1993-03-04
AU2426392A (en) 1993-03-16
PT100801A (en) 1993-09-30
CN1069969A (en) 1993-03-17
BR9206403A (en) 1994-12-27
IL102835A0 (en) 1993-01-31
HU9400503D0 (en) 1994-05-30

Similar Documents

Publication Publication Date Title
DE3875782T2 (en) LEUCOTRIA ANTAGONISTS.
DE68915207T2 (en) Amino acid derivatives.
DE59008394D1 (en) Amino acid amide derivatives.
DK340088A (en) AMINO ACID DERIVATIVES
NO901399D0 (en) Amino acid derivative.
NO901033L (en) Amino acid derivative.
DE3688691T2 (en) Salt-resistant polyamide composition.
MX9204866A (en) SYNTHETIC ARYLPOLYAMINS AS ANTAGONISTS OF EXCITING AMINO ACID NEUROTRANSMITTERS.
NO892416D0 (en) Polyamides.
FI901765A0 (en) SYNTHETIC GEN.
DK530888A (en) LEUKOTRIEN -LTD4- AND - LTB4 ANTAGONISTS
BR9206404A (en) Synthetic heteroaryl-polyamines as antagonists of excitatory amino acid neurotransmitters
NO884434D0 (en) Amino acid derivative.
FI901763A0 (en) SYNTHETIC GEN.
DE59301060D1 (en) Substituted amino acid amides.
IT8224380A0 (en) PHOSPHYNYLALKANOIC AMINO ACIDS USEFUL AS HYPOTENSIVE AGENTS.
DE3875030T2 (en) LEUKOTRIA ANTAGONISTS.
DE69018816T2 (en) AMINO ACID DERIVATIVES.
NO901519L (en) Amino acid derivative.
MX9203754A (en) LEUCOTRENE ANTAGONISTS.
FI884255A (en) L-ASPARTYL-3- (BICYCLOALKYL) -L-ALANINALKYLESTRAR MED HOEG SOETHETSGRAD.
DE3850945D1 (en) Polyamide composition.
MX9203743A (en) THIOPHENYLALCANOIC ACIDS USEFUL AS LEUCOTRENE ANTAGONISTS
LV5808A4 (en) Lh1 antagonists
KR900700012A (en) Foliar spray